Skip to content Skip to footer

CEAS Collective: Bridging Biotech Innovation and Consumer Wellness Through Direct-to-Patient Delivery 

Biotech innovation is rapidly transforming the boundaries of modern wellness, and CEAS  Collective stands at the forefront of this shift. By integrating advanced product  development with a direct-to-patient delivery model, CEAS Collective bridges the gap  between next-generation health solutions and consumer-centric care. Their approach  sets a new benchmark for accessible, holistic wellness, offering patients seamless  access to science-driven products…

Read more

Roadblocks to Specialty Medicines Access: Colin Banas from DrFirst in Conversation with PharmaShots

Roadblocks to Specialty Medicines Access: Colin Banas from DrFirst in Conversation with PharmaShots 

Shots:  Fragmented workflows continue to be a major roadblock in the healthcare ecosystem, causing unnecessary delays in care delivery  Automated solutions help bridge the gaps resulting from disjointed workflows and expedite prior authorization, pharmacy routing, and patient onboarding  Colin Banas, CMO at DrFirst, joins PharmaShots in a discussion highlighting the company’s recent acquisition of Myndshft…

Read more